8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,710) Views
Editor in Chief Professor Garry Walsh
1178-203X
Effectiveness of lifestyle measures in the treatment of gastroesophageal reflux disease – a case series
Madeleine Nowak, Petra Büttner, Simone Harrison, Kym Daniell, Beverly Raasch, Rick Speare
Therapeutics and Clinical Risk Management 2006, 2:329-334
12 May 2006
An assessment of the cost-utility of therapy for psoriasis
Stefan C Weiss, Wingfield Rehmus, Alexa B Kimball
Therapeutics and Clinical Risk Management 2006, 2:325-328
09 October 2006
Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model
Carin A Uyl-de Groot, Joseph McDonnell, Guul ten Velde, David Radice, Harry J M Groen
Therapeutics and Clinical Risk Management 2006, 2:317-323
09 October 2006
Impact of introducing anticoagulation-related prescribing guidelines in a hospital setting using academic detailing
Gregory William Roberts, Robert Adams
Therapeutics and Clinical Risk Management 2006, 2:309-316
09 October 2006
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine
Ebrahim A Balbisi
Therapeutics and Clinical Risk Management 2006, 2:303-308
21 September 2006
Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
Steven Cheng, Daniel Coyne
Therapeutics and Clinical Risk Management 2006, 2:297-301
12 May 2006
Management of age-related osteoporosis and prevention of associated fractures
Eric J MacLaughlin, Rebecca B Sleeper, Danny McNatty, Cynthia L Raehl
Therapeutics and Clinical Risk Management 2006, 2:281-295
09 October 2006
Bortezomib (Velcade™) in the treatment of multiple myeloma
Antonia Field-Smith, Gareth J Morgan, Faith E Davies
Therapeutics and Clinical Risk Management 2006, 2:271-279
12 May 2006
Progress in the development of a cervical cancer vaccine
Ursula Winters, Richard Roden, Henry Kitchener, Peter Stern
Therapeutics and Clinical Risk Management 2006, 2:259-269
09 October 2006
Cancer treatment-induced mucositis pain: strategies for assessment and management
Debra J Harris
Therapeutics and Clinical Risk Management 2006, 2:251-258
09 October 2006
Alendronate sodium in the management of osteoporosis
P J J Prinsloo, DJ Hosking
Therapeutics and Clinical Risk Management 2006, 2:235-249
09 October 2006
Oxycodone controlled release in cancer pain management
Giuseppe Biancofiore
Therapeutics and Clinical Risk Management 2006, 2:229-234
21 September 2006
Editorial ||FREE PAPER||
Garry Walsh
Therapeutics and Clinical Risk Management 2006, 2:227-228
12 May 2006
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
